Simrat Randhawa

Dr. Simrat Randhawa is a medical doctor who currently serves as the Chief Medical Officer at Dianthus Therapeutics. Prior to their current position, they served as the Senior Vice President of Medical and Clinical Affairs at Aurinia Pharmaceuticals Inc. from February 2017 to April 2022. Dr. Randhawa has also worked as the Global Medical Director at BioMarin Pharmaceutical Inc. from July 2015 to April 2017, and as the Lead Medical Director for Multiple Sclerosis at Novartis from December 2008 to April 2022. Prior to their career in medicine, Dr. Randhawa worked as an Engagement Manager at McKinsey from July 2005 to December 2008. Simrat received their medical degree from the University of Medicine and Dentistry New Jersey (UMDNJ) in 1995 and completed their residency in general surgery at UMDNJ in 2001.

Simrat Randhawa's educational career includes completing an MBA at Columbia Business School and an MD at Drexel University College of Medicine. Simrat then went on to complete an MD in General Surgery at Rutgers University.

They are on a team with Polly Hanff - Head of Quality, Scott Nogi - VP, Operations, and Edward Carr - Chief Accounting Officer. Their manager is Marino Garcia, President & Chief Executive Officer.